AVIDITY BIOSCIENCES INC's ticker is RNA and the CUSIP is 05370A108. A total of 112 filers reported holding AVIDITY BIOSCIENCES INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $25,612,445 | -41.8% | 4,014,490 | +1.2% | 0.00% | 0.0% |
| Q2 2023 | $43,996,082 | -17.7% | 3,967,185 | +13.9% | 0.00% | 0.0% |
| Q1 2023 | $53,444,356 | -30.6% | 3,481,717 | +0.3% | 0.00% | -50.0% |
| Q4 2022 | $77,013,192 | +74.8% | 3,470,626 | +28.6% | 0.00% | +100.0% |
| Q3 2022 | $44,064,000 | +25.2% | 2,698,376 | +11.4% | 0.00% | 0.0% |
| Q2 2022 | $35,194,000 | -17.1% | 2,422,122 | +5.4% | 0.00% | 0.0% |
| Q1 2022 | $42,451,000 | -10.9% | 2,298,363 | +14.7% | 0.00% | 0.0% |
| Q4 2021 | $47,624,000 | -0.5% | 2,003,572 | +3.1% | 0.00% | 0.0% |
| Q3 2021 | $47,847,000 | +52.3% | 1,942,613 | +52.7% | 0.00% | 0.0% |
| Q2 2021 | $31,426,000 | +12.3% | 1,271,798 | -0.9% | 0.00% | 0.0% |
| Q1 2021 | $27,985,000 | +34.7% | 1,283,071 | +57.6% | 0.00% | 0.0% |
| Q4 2020 | $20,782,000 | -1.5% | 814,326 | +8.7% | 0.00% | 0.0% |
| Q3 2020 | $21,093,000 | +3633.3% | 749,271 | +3646.4% | 0.00% | – |
| Q2 2020 | $565,000 | – | 20,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 849,651 | $13,042,143 | 13.77% |
| COWEN AND COMPANY, LLC | 4,592,966 | $70,502,028 | 8.28% |
| Cormorant Asset Management, LP | 2,612,115 | $40,096 | 2.64% |
| 5AM Venture Management, LLC | 665,555 | $10,216,269 | 2.61% |
| RA Capital Management | 6,416,998 | $98,500,919 | 2.23% |
| RTW INVESTMENTS, LP | 6,387,178 | $98,043,182 | 2.04% |
| COMMODORE CAPITAL LP | 590,705 | $9,067,322 | 1.38% |
| Casdin Capital, LLC | 850,000 | $13,047,500 | 1.08% |
| Boxer Capital, LLC | 1,121,327 | $17,212 | 0.85% |
| Octagon Capital Advisors LP | 382,000 | $5,863,700 | 0.84% |